James A Shayman and Andrea S Kevrick Professor of Translational Medicine
Professor of Internal Medicine
Professor of Pharmacology
[email protected]
Available to mentor
Richard Auchus
Professor
Steroid biochemistry and related disorders; secondary causes of diabetes and their treatments.
-
MDWashington University in St. Louis School of Medicine, St Louis, 1988
-
PhDWashington University in St. Louis School of Medicine, St Louis, 1988
-
Center MemberSamuel and Jean Frankel Cardiovascular Center
-
Center MemberCaswell Diabetes Institute
-
Center MemberRogel Cancer Center
-
Center MemberCenter for Cell Plasticity and Organ Design
-
Center MemberGlobal REACH
Steroid biochemistry and related disorders; secondary causes of diabetes and their treatments.
-
Yu X, Zhao QY, Yaman M, Emly SM, Lee JK, Su H, Ferguson AC, Nagaswami C, Chaturantabut S, Goessling W, Weisel JW, Auchus RJ, Shavit JA. 2024 Nov 15;PreprintHormone-induced thrombosis is mediated through non-canonical fibrin(ogen) aggregation and a novel estrogen target in zebrafish.
DOI:10.1101/2024.11.13.623199 PMID: 39605542 -
Charoensri S, Auchus RJ. J Clin Endocrinol Metab, 2024 Oct 15; 109 (11): e2164 - e2165.Journal ArticleResponse to Letter to the Editor From Tang and Zhang: "Predictors of Cardiovascular Morbidities in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia".
DOI:10.1210/clinem/dgae402 PMID: 38922819 -
Auchus RJ, Sturgeon J, Lin VH. N Engl J Med, 2024 Oct 24; 391 (16): 1557 - 1558.Journal ArticleCrinecerfont in Adult Congenital Adrenal Hyperplasia. Reply.
DOI:10.1056/NEJMc2411263 PMID: 39442053 -
Srirangalingam U, Velusamy A, Binderup ML, Baker B, Flensburg MF, Boserup LP, Luthman J, Benecke H, Auchus RJ. Journal of the Endocrine Society, 2024 Oct 5; 8 (Supplement_1): bvae163.285Journal Article12484 Safety And Pharmacokinetics Of Anti-ACTH Antibody Lu AG13909 In Patients With Classic Congenital Adrenal Hyperplasia: Phase 1 Open-label, Multiple-Ascending-Dose Trial Protocol
DOI:10.1210/jendso/bvae163.285 -
Auchus RJ, Trainer PJ, Lucas KJ, Bruera D, Marko J, Ayala A, Wu Y, Ferrara-Cook CT, De La Torre E, Krasner A, Lagast H, Luo R, Bachega TASS, Struthers RS, Betz SF, Srirangalingam U. Journal of the Endocrine Society, 2024 Oct 5; 8 (Supplement_1): bvae163.249Journal Article12537 Once Daily Oral Atumelnant (CRN04894) Induces Rapid And Profound Reductions Of Androstenedione And 17-Hydroxyprogesterone In Participants With Classical Congenital Adrenal Hyperplasia: Initial Results From A 12-Week, Phase 2, Open-Label Study
DOI:10.1210/jendso/bvae163.249 -
Fleseriu M, Pivonello R, Newell-Price J, Gadelha M, Auchus RJ, Feelders R, Lacroix A, Shimatsu A, Witek P, Bex M, Piacentini A, Pedroncelli AM, Biller BM. Journal of the Endocrine Society, 2024 Oct 5; 8 (Supplement_1): bvae163.1175Journal Article6907 Continued Improvements in Hypertension and Diabetes During Long-Term Osilodrostat Therapy in Patients with Cushing’s Disease: A Pooled Analysis from the Phase III LINC 3 and LINC 4 Studies
DOI:10.1210/jendso/bvae163.1175 -
Auchus RJ, Hamidi O, Pivonello R, Bancos I, Russo G, Witchel SF, Isidori AM, Rodien P, Srirangalingam U, Kiefer FW, Falhammar H, Merke DP, Reisch N, Sturgeon J, Roberts E, Lin VH, Chan JL, Farber R. Journal of the Endocrine Society, 2024 Oct 5; 8 (Supplement_1): bvae163.128Journal Article7152 CAHtalyst: Results From The Randomized, Double-Blind, Placebo-Controlled Period Of A Phase 3 Trial Of Crinecerfont, A Corticotropin-Releasing Factor Type 1 Receptor (CRF1) Antagonist, In Adults With Classic Congenital Adrenal Hyperplasia
DOI:10.1210/jendso/bvae163.128 -
Lee C, Auchus RJ, McDonald J, Rege J, Rainey WE, Turcu AF. Journal of the Endocrine Society, 2024 Oct 5; 8 (Supplement_1): bvae163.277Journal Article7212 Racial/Ethnical Differences In Classic And 11-Oxygenated Androgens
DOI:10.1210/jendso/bvae163.277
Department News
Dr. Rich Auchus at the University of Michigan Medical School was quoted in CNN article.
